Medmain and SMC Sign Partnership to Launch AI-Powered Pathological Diagnosis Support in Vietnam
On July 1, 2025, Medmain Inc. (Headquartered in Fukuoka City, Fukuoka Prefecture, CEO: Osamu Iizuka), a developer and provider of AI-powered cloud system for digital pathology, and SMC Co., Ltd., Medical Tourism Japan Division, (Headquartered in Sapporo City, Hokkaido, Division Director: Mr. Katsuya Sakagami) which supports medical tourism and the overseas expansion of Japanese medical technologies, signed a partnership agreement to promote the research use of AI in the field of pathological diagnosis in the Socialist Republic of Vietnam and to advance the adoption of Japanese-style healthcare.
■Background and Purpose of the Partnership
Medmain Inc. has a corporate mission “To create a world where medical services can be accessed with technology anywhere, anytime”, and develops and provides PidPort, an AI-powered cloud system for digital pathology that is increasingly being adopted by medical institutions worldwide.
Meanwhile, SMC Co., Ltd., Medical Tourism Japan Division focuses on medical tourism and supporting the international expansion of Japan’s advanced medical technologies, while promoting medical collaboration with other countries, particularly in Asia.
This partnership aims to jointly promote the use of AI in the field of pathological diagnosis in Vietnam, and we will contribute to its advancement through the research and application of AI in local medical institutions.
■Future Outlook
Based on this agreement, we will advance the following initiatives.
・Research and introduction of an AI-powered pathological diagnosis support system in collaboration with medical institutions in Vietnam
・Joint development of educational and promotional activities related to Japanese-style healthcare
・Promotion of digital transformation (DX) in the medical field
・Contribution to global health through the international sharing of medical quality standards
By combining Medmain’s technological capabilities with SMC’s expertise in international expansion, we are committed to delivering sustainable, high-quality medical services that meet local needs.
